Core Laboratories Inc.

CLB Energy Oil & Gas Equipment & Services

Core Laboratories Inc.’s revenue for fiscal 2025 (year ended December 2025) was $526.5 million, up 0.51% from fiscal 2024. In the quarter to June 2026, revenue fell 4.26%, EPS fell 43.5%, free cash flow fell 65.7% and total debt fell 8.63%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for three; insiders bought in the last twelve months.

9.98 0.20 +2.04%
Market cap
$448.8M
P/E
19.2×
Fwd P/E
28.1×
Dividend yield
0.40%
F-score
7/9
Altman Z
3.29
Beneish M
−2.56
Dividend safety
82/100

Core Laboratories Inc. (CLB) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Core Laboratories Inc. (CLB) trades at a EV/Sales of 1.2×. Over the past ten years it has ranged from 1.0× (March 2020) to 9.6× (January 2017); the current reading is higher than 1% of that period. That is below the Oil & Gas Equipment & Services industry median of 1.3× and below the Energy sector median of 2.3×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 1.7× (9.21%)
FY2024 1.9× (6.97%)
FY2023 2.0× (10.56%)
FY2022 2.3× (15.74%)
FY2021 2.7× (12.09%)
FY2020 3.1× 4.03%
FY2019 3.0× (28.84%)
FY2018 4.2× (47.77%)
FY2017 8.0× (14.47%)
FY2016 9.3× 46.79%

Quarterly newest first

Period EV/Sales Change
Jun 2026 1.4× (24.49%)
Mar 2026 1.8× 4.04%
Dec 2025 1.7× 21.21%
Sep 2025 1.4× 4.18%
42 more quarters

Against its own ten years

Low 1.0× High 9.6×
Ten-year median 3.2×
Current reading's percentile 1

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on CLB